Oral Administration of PLGA Nanoparticles to Deliver Antisense Oligonucleotides to Inflammatory Lesions in the Gastrointestinal Tract-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral Administration of PLGA Nanoparticles to Deliver Antisense Oligonucleotides to Inflammatory Lesions in the Gastrointestinal Tract

Published:2024-04-15 Issue:4 Volume:47 Page:848-855
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Yagi Yuta¹²,Liu Yiwei³,Li Jinting²,Shimada Shunsuke¹,Ohkouchi Munetaka¹,Taguchi Yasushi¹,Nii Teruki³,Mori Takeshi³⁴,Katayama Yoshiki³⁴⁵⁶⁷

Affiliation:

1. Research Center, Mochida Pharmaceutical Co., Ltd.

2. Graduate School of Systems Life Sciences, Kyushu University

3. Department of Applied Chemistry, Faculty of Engineering, Kyushu University

4. Center for Future Chemistry, Kyushu University

5. Center for Molecular Systems, Kyushu University

6. Center for Advanced Medical Open Innovation, Kyushu University

7. Department of Biomedical Engineering, Chung Yuan Christian University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/4/47_b23-00769/_pdf

Reference38 articles.

1. 1) Gisbert JP, Panés J. Loss of response and requirement of infliximab dose intensification in Crohn’s disease: a review. Am. J. Gastroenterol., 104, 760–767 (2009).

2. 2) Lichtenstein GR, Rutgeerts P, Sandborn WJ, Sands BE, Diamond RH, Blank M, Montello J, Tang L, Cornillie F, Colombel JF. A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease. Am. J. Gastroenterol., 107, 1051–1063 (2012).

3. 3) Marafini I, Monteleone G. Inflammatory bowel disease: new therapies from antisense oligonucleotides. Ann. Med., 50, 361–370 (2018).

4. 4) van Deventer SJH, Tami JA, Wedel MK. A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis. Gut, 53, 1646–1651 (2004).

5. 5) Monteleone G, Neurath MF, Ardizzone S, et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn’s disease. N. Engl. J. Med., 372, 1104–1113 (2015).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3